TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
AIMS/HYPOTHESIS: The gene encoding transcription factor 7-like 2 (TCF7L2) has been identified as a type 2 diabetes locus from genome-wide linkage studies and subsequent association analysis. We investigated the role of two common variants in TCF7L2 in a large case-control study recruited from the T...
Main Authors: | Kimber, C, Doney, A, Pearson, E, McCarthy, M, Hattersley, A, Leese, G, Morris, A, Palmer, C |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2007
|
Títulos similares
-
Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
por: Pearson, E, et al.
Publicado: (2007) -
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
por: Zhou, K, et al.
Publicado: (2009) -
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.
por: Zhou, K, et al.
Publicado: (2010) -
Pharmacogenetics in Type 2 diabetes: variation in TCF7L2 influences response to sulphonylureas
por: Pearson, E, et al.
Publicado: (2007) -
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with Type 2 diabetes: A Go-DARTS study
por: Donnelly, L, et al.
Publicado: (2011)